Subscribe to Newsletter

March 2015 Issue of The Medicine Maker

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Manufacture Small Molecules

Practical Innovation

| Charlotte Barker

It's important to remember that innovation in pharma isn’t synonymous with drug discovery.

Manufacture Biosimilars

America’s Most Wanted: Biosimilars

| Charlotte Barker

We catch up with Carol Lynch, Global Head of Biopharmaceuticals & Oncology Injectables at Sandoz.

Discovery & Development Clinical Trials

Silent Data

| Stephanie Vine

Information from “stalled” drug trials should be published, not tossed aside

Manufacture Small Molecules

Rewarding Humanity

| Stephanie Vine

An antimalarial medicine-making project wins the inaugural Humanity in Science Award.

Business & Regulation Business Practice

Mining Social Media

| Stephanie Vine

New technology interprets slang and banter to find out what people really think

Business & Regulation Packaging

Personalized Labels

| Stephanie Vine

Just how prevalent is pharmacogenomic information on European drug labels?

Discovery & Development Standards & Regulation

Premature Revelation

| Stephanie Vine

FDA scolds company for revealing interim trial results

Business & Regulation Business Practice

Funding Dementia Discovery

| Stephanie Vine

$100 million pledged to kick start investment in new research

Discovery & Development Formulation

Small Pharma

| Helen Sammons

Legislation on pediatric medicines is sowing the seeds for a better future, but we must maintain momentum if children are to get the best possible care.

Business & Regulation Business Practice

Supplying Health to the Whole World

| Natalie Privett

Without proper supply chain management, efforts to supply drugs to the developing world are wasted.

Manufacture Small Molecules

Kicking Batch Habits

| Richard Fazackerley

The industry has been dipping its toe into the water of continuous manufacturing for years.

Manufacture Business Practice

The Big Break for Biosimilars?

| Stephanie Vine

The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.

Discovery & Development Drug Delivery

Remote Controlled Drugs

| Brian P. Timko, Daniel S. Kohane

The latest devices can deliver a drug in the right place and at the right time at the push of a button.

Discovery & Development Drug Delivery

Nonthreatening Needles

| Lifeng Kang

No-one likes getting injections. Fortunately, patients may soon have a pain-free alternative in the form of microneedle delivery systems.

Business & Regulation Business Practice

The Challenge of China

| Fadia AlKhalil

The potential for growth is huge, but how do you break into the market?

Discovery & Development Clinical Trials

Advocate of Change

| Charlotte Barker

Phyllis Greenberger, President and CEO of the Society for Women’s Health Research (SWHR).

Discovery & Development Drug Delivery

The Toolbox of 2025

| Charlotte Barker

What techniques will be in the toolbox 10 years from now? We speak to academic and industry experts to find out.

Discovery & Development Analytical Science

A Sweet Revolution

| Ken Cook

Glycan analysis poses major challenges for the biopharma industry; how can new technology lighten the load?

teaser of 0315-903
Manufacture Biosimilars

Monitoring Biosimilars

| Stephanie Vine

We speak to Professor Begoña Calvo to find out more about her research into pharmaco vigilance for biosimilars.

Other issues of 2015